Evofem Biosciences, Inc.
EVFM
$0.0097
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -106.13% | -116.72% | -116.97% | -13.98% | 207.12% |
| Total Depreciation and Amortization | 254.92% | 36.06% | -50.64% | -91.50% | -75.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.80% | 105.15% | 97.52% | 33.82% | -966.45% |
| Change in Net Operating Assets | -66.26% | -81.66% | 52.34% | 6.34% | 570.17% |
| Cash from Operations | 11.70% | 56.68% | 89.26% | 87.86% | 92.83% |
| Capital Expenditure | 100.00% | -250.00% | 64.10% | 87.16% | 94.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3,980.00% | -14,125.00% | -1,241.03% | 87.16% | 94.60% |
| Total Debt Issued | -90.08% | -92.96% | -88.54% | 7.17% | 27.39% |
| Total Debt Repaid | 20.54% | 32.24% | 33.10% | -- | 80.41% |
| Issuance of Common Stock | 2,083.41% | 1,624.14% | -33.33% | -97.08% | -99.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 391.55% | -- |
| Cash from Financing | 45.69% | -3.37% | -58.19% | -53.23% | -93.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 149.70% | 103.84% | 103.31% | 100.26% | 86.37% |